These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31444050)

  • 1. Endocrine characteristics, body mass index and metabolic syndrome in women with polycystic ovary syndrome.
    Li J; Wu Q; Wang CC; Wang R; Ng EHY; Liu JP; Mol BWJ; Wu XK; Li WT;
    Reprod Biomed Online; 2019 Nov; 39(5):868-876. PubMed ID: 31444050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of exposure to second-hand smoke from husbands on biochemical hyperandrogenism, metabolic syndrome and conception rates in women with polycystic ovary syndrome undergoing ovulation induction.
    Li J; Wu Q; Wu XK; Zhou ZM; Fu P; Chen XH; Yan Y; Wang X; Yang ZW; Li WL; Stener-Victorin E; Legro RS; Ng EH; Zhang H; Mol BWJ; Wang CC;
    Hum Reprod; 2018 Apr; 33(4):617-625. PubMed ID: 29471520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive markers for the FSH sensitivity of women with polycystic ovarian syndrome.
    Köninger A; Sauter L; Edimiris P; Kasimir-Bauer S; Kimmig R; Strowitzki T; Schmidt B
    Hum Reprod; 2014 Mar; 29(3):518-24. PubMed ID: 24419495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations.
    Huang CC; Tien YJ; Chen MJ; Chen CH; Ho HN; Yang YS
    Hum Reprod; 2015 Apr; 30(4):937-46. PubMed ID: 25662806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
    Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between blood cadmium and endocrine features related to PCOS-phenotypes in healthy women of reproductive age: a prospective cohort study.
    Kim K; Pollack AZ; Nobles CJ; Sjaarda LA; Zolton JR; Radoc JG; Schisterman EF; Mumford SL
    Environ Health; 2021 May; 20(1):64. PubMed ID: 34022900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of hyperhomocysteinaemia and metabolic syndrome on reproduction in women with polycystic ovary syndrome: a secondary analysis.
    Chang H; Xie L; Ge H; Wu Q; Wen Y; Zhang D; Zhang Y; Ma H; Gao J; Wang CC; Stener-Victorin E; Ng EH; Wu X
    Reprod Biomed Online; 2019 Jun; 38(6):990-998. PubMed ID: 30979610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
    Yue CY; Lu LK; Li M; Zhang QL; Ying CM
    PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of polycystic ovary syndrome in a normal population according to the Rotterdam criteria versus revised criteria including anti-Mullerian hormone.
    Lauritsen MP; Bentzen JG; Pinborg A; Loft A; Forman JL; Thuesen LL; Cohen A; Hougaard DM; Nyboe Andersen A
    Hum Reprod; 2014 Apr; 29(4):791-801. PubMed ID: 24435776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG; Guo Y; Ma LA; Xing J; Sun RF; Zhu W
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen levels in women with various forms of ovarian dysfunction: associations with cardiometabolic features.
    Daan NM; Jaspers L; Koster MP; Broekmans FJ; de Rijke YB; Franco OH; Laven JS; Kavousi M; Fauser BC
    Hum Reprod; 2015 Oct; 30(10):2376-86. PubMed ID: 26269538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
    Bradbury RA; Lee P; Smith HC
    Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Androgen Levels, Endocrine and Metabolic Indices, and Clinical Findings in Women with Polycystic Ovary Syndrome in Uygur and Han Ethnic Groups from Xinjiang Province in China.
    Zhao H; Song X; Zhang L; Xu Y; Wang X
    Med Sci Monit; 2018 Sep; 24():6774-6780. PubMed ID: 30252834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of different molecular forms of antimüllerian hormone and biomarkers of polycystic ovary syndrome and normal women.
    Wissing ML; Mikkelsen AL; Kumar A; Kalra B; Pors SE; Flachs EM; Andersen CY
    Fertil Steril; 2019 Jul; 112(1):149-155.e1. PubMed ID: 31056306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of metabolic syndrome is higher among non-obese PCOS women with hyperandrogenism and menstrual irregularity in Korea.
    Kim MJ; Lim NK; Choi YM; Kim JJ; Hwang KR; Chae SJ; Park CW; Choi DS; Kang BM; Lee BS; Kim T; Park HY
    PLoS One; 2014; 9(6):e99252. PubMed ID: 24901345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.